Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
Joanna L KaplanLance C VisserCatherine T Gunther-HarringtonEric S OntiverosLuke A WittenburgCarrie A PalmJoshua A SternPublished in: Journal of veterinary internal medicine (2022)
Results suggest that pimobendan (SD_pimo or HD_pimo) might not affect renal function in nonazotemic dogs with stage B2 MMVD. High-dose pimobendan did not demonstrate advantages over SD_pimo within the constraints of our study.